DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Moreau P, Mateos MV, Berenson JR, Weisel K, Lazzaro A, Song K. et al.
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W): Interim analysis results of a randomised, phase 3 study.
Lancet Oncol 2018;
19: 953-64
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.